IPSC vs PODD · rev $6.6M vs P/E 34, rev $2.07B
Century Therapeutics Inc (IPSC) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
IPSC currently screens at market cap $47.8M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the IPSC and PODD stock pages for the full models.
Not investment advice.